The global interest in zero liquid discharge is likely to increase over the coming decades and regulations will force companies to continue adopting this technology.

Successful harnessing of the opportunities for growth in the ophthalmic pharmaceuticals market will depend upon the development of novel products with technologies that increase clinical effectiveness and development of products for previously-untreated ophthalmic conditions.

The industry’s outlook also appears promising, due partly to escalating tensions between state actors and deteriorating security situations in the Arabian Peninsula and North Africa

So far, little has actually been achieved in terms of carbon emissions reductions. Some investment by various countries into low net carbon energy sources (wind, solar) has actually increased their total carbon emissions (most notably Germany).